Genmab A/S

Genmab A/S Forward P/E

The Forward P/E Ratio of Genmab A/S (GMAB.CO) as of Nov 16, 2026 is 17.37. In the previous year, Forward P/E Ratio was 14.34 — a change of 21.08% (higher).

Forward P/E

17.37

YoY

21.08%

Last updated:

Forward P/E Ratio of Genmab A/S is 2025 17.37 . Forward P/E Ratio of Genmab A/S was 2024 14.34 . It decreases by 21.08% higher compared to the previous year.

The Genmab A/S Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
76.43 USD
Jan 1, 2019
51.95 USD
Jan 1, 2020
23.65 USD
Jan 1, 2021
38.05 USD
Jan 1, 2022
20.64 USD
Jan 1, 2023
25.85 USD
Jan 1, 2024
14.34 USD
Jan 1, 2025
17.37 USD
The Genmab A/S Forward P/E history
YEARForward P/EYoY
17.37+21.08%
14.34-44.52%
25.85+25.28%
20.64-45.76%
38.05+60.91%
23.65-54.48%
51.95-32.03%
76.43-25.04%
101.96+7.57%
94.78-35.68%
147.36-60.54%
373.43—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Forward P/E Ratio of Genmab A/S is 17.37 in 2025.

Forward P/E Ratio of Genmab A/S changed from 14.34 to 17.37, representing a 21.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Genmab A/S

All Key Metrics — Genmab A/S